| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
23,314 |
22,174 |
$13.50M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
32,520 |
31,592 |
$3.80M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,857 |
3,574 |
$1.66M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,288 |
1,247 |
$1.30M |
| 87428 |
|
16,484 |
15,977 |
$378K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,108 |
536 |
$354K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,539 |
2,451 |
$255K |
| 59025 |
Fetal non-stress test |
1,900 |
1,196 |
$201K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
36,910 |
32,951 |
$135K |
| 80053 |
Comprehensive metabolic panel |
29,916 |
27,033 |
$112K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,030 |
1,754 |
$89K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,632 |
6,132 |
$82K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
763 |
732 |
$77K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,880 |
1,824 |
$63K |
| 71045 |
Radiologic examination, chest; single view |
7,844 |
7,379 |
$63K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,466 |
1,396 |
$62K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
387 |
131 |
$41K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,394 |
1,324 |
$40K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,371 |
4,255 |
$35K |
| 86850 |
|
1,219 |
1,149 |
$35K |
| 86780 |
|
1,886 |
1,824 |
$35K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,496 |
2,386 |
$34K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,224 |
5,754 |
$33K |
| 36415 |
Collection of venous blood by venipuncture |
55,071 |
41,047 |
$32K |
| 84702 |
|
3,195 |
2,857 |
$31K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
794 |
794 |
$27K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,420 |
3,217 |
$26K |
| 81001 |
|
12,887 |
11,982 |
$20K |
| 74018 |
|
362 |
340 |
$19K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,602 |
1,412 |
$18K |
| 87400 |
|
2,855 |
2,783 |
$14K |
| 86762 |
|
664 |
591 |
$13K |
| 83690 |
|
5,151 |
4,821 |
$12K |
| 76801 |
|
102 |
88 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
165 |
160 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,498 |
1,269 |
$10K |
| 84484 |
|
3,841 |
3,083 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
83 |
58 |
$9K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
767 |
767 |
$9K |
| 87340 |
|
700 |
680 |
$9K |
| 80061 |
Lipid panel |
3,159 |
3,115 |
$9K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
520 |
427 |
$8K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
579 |
579 |
$8K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
703 |
184 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
234 |
212 |
$7K |
| 87430 |
|
810 |
804 |
$6K |
| 86803 |
|
320 |
314 |
$6K |
| 83880 |
|
1,475 |
1,359 |
$6K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
185 |
183 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,726 |
2,692 |
$5K |
| 86900 |
|
1,891 |
1,766 |
$5K |
| 86901 |
|
1,898 |
1,769 |
$5K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
26 |
26 |
$4K |
| 87081 |
|
535 |
531 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
422 |
417 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
122 |
116 |
$3K |
| 87420 |
|
504 |
500 |
$3K |
| J3490 |
Unclassified drugs |
1,554 |
1,141 |
$3K |
| 85027 |
|
568 |
541 |
$3K |
| 87077 |
|
2,044 |
1,862 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
337 |
324 |
$3K |
| 76642 |
|
58 |
52 |
$2K |
| 82947 |
|
722 |
688 |
$2K |
| 81003 |
|
2,951 |
2,765 |
$2K |
| 81025 |
|
453 |
431 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,761 |
2,575 |
$2K |
| 0002A |
|
94 |
93 |
$2K |
| 85610 |
|
3,871 |
3,044 |
$2K |
| 84439 |
|
1,050 |
1,028 |
$2K |
| 82951 |
|
121 |
120 |
$2K |
| 85730 |
|
2,143 |
2,031 |
$2K |
| 99215 |
Prolong outpt/office vis |
18 |
12 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
750 |
677 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,192 |
2,013 |
$2K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
12 |
12 |
$2K |
| 86140 |
|
1,515 |
1,426 |
$2K |
| 87040 |
|
676 |
564 |
$2K |
| 82105 |
|
90 |
88 |
$2K |
| 83605 |
|
850 |
770 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15 |
15 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,061 |
1,048 |
$1K |
| 0001A |
|
104 |
103 |
$1K |
| 85651 |
|
1,040 |
999 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
406 |
398 |
$1K |
| 93296 |
|
316 |
316 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,804 |
2,456 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
15 |
12 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,030 |
1,932 |
$1K |
| 77080 |
|
319 |
319 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
317 |
214 |
$1K |
| 86787 |
|
56 |
54 |
$1K |
| 72100 |
|
109 |
108 |
$1K |
| 93017 |
|
53 |
53 |
$1K |
| 82950 |
|
146 |
145 |
$994.08 |
| 96376 |
|
59 |
44 |
$987.83 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
27 |
27 |
$954.27 |
| 80047 |
|
738 |
678 |
$934.02 |
| 87147 |
|
364 |
356 |
$931.97 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,122 |
1,834 |
$780.60 |
| 82140 |
|
322 |
282 |
$732.92 |
| 84145 |
|
106 |
99 |
$732.79 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
18 |
16 |
$712.81 |
| 82607 |
|
681 |
667 |
$705.63 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
18 |
18 |
$606.23 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
18 |
18 |
$606.23 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
18 |
18 |
$606.23 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
750 |
557 |
$586.23 |
| 82728 |
|
348 |
341 |
$494.27 |
| J2785 |
Injection, regadenoson, 0.1 mg |
39 |
39 |
$487.12 |
| 93280 |
|
43 |
43 |
$453.29 |
| 82077 |
|
146 |
132 |
$416.08 |
| 85014 |
|
1,357 |
1,240 |
$411.07 |
| 82746 |
|
416 |
411 |
$392.49 |
| 82150 |
|
93 |
90 |
$370.02 |
| 82565 |
|
1,021 |
983 |
$345.59 |
| 82570 |
|
743 |
709 |
$343.99 |
| 88342 |
|
14 |
14 |
$338.54 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
44 |
42 |
$288.62 |
| 93880 |
|
13 |
13 |
$239.78 |
| 82550 |
|
207 |
196 |
$226.44 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
392 |
368 |
$205.13 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
921 |
847 |
$196.55 |
| 97161 |
|
12 |
12 |
$191.97 |
| 83550 |
|
245 |
236 |
$188.61 |
| 80051 |
|
290 |
272 |
$175.94 |
| 87186 |
|
154 |
144 |
$171.45 |
| 73560 |
|
18 |
13 |
$167.05 |
| J1644 |
Injection, heparin sodium, per 1000 units |
354 |
216 |
$166.98 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
376 |
357 |
$159.20 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
134 |
91 |
$151.13 |
| 87070 |
|
165 |
149 |
$145.25 |
| 87205 |
|
215 |
185 |
$142.42 |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
53 |
53 |
$132.54 |
| 84100 |
|
298 |
261 |
$121.86 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
52 |
52 |
$121.80 |
| 83735 |
|
13 |
12 |
$118.49 |
| 83970 |
|
29 |
28 |
$91.24 |
| 82043 |
|
575 |
572 |
$87.10 |
| 84156 |
|
103 |
98 |
$86.58 |
| 93971 |
|
12 |
12 |
$84.56 |
| 82962 |
|
1,729 |
1,134 |
$76.14 |
| 80069 |
|
157 |
145 |
$70.68 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
39 |
38 |
$66.38 |
| 85007 |
|
17 |
17 |
$57.00 |
| 80164 |
|
230 |
215 |
$56.85 |
| 85378 |
|
26 |
25 |
$46.64 |
| 84520 |
|
297 |
279 |
$36.90 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
358 |
333 |
$31.02 |
| 80076 |
|
91 |
90 |
$25.92 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,551 |
1,473 |
$22.08 |
| 83540 |
|
30 |
29 |
$19.98 |
| 84436 |
|
40 |
40 |
$19.62 |
| J1940 |
Injection, furosemide, up to 20 mg |
20 |
14 |
$16.23 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
13 |
12 |
$12.29 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
901 |
878 |
$12.17 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
15 |
12 |
$10.07 |
| 94760 |
|
19 |
13 |
$5.01 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,226 |
1,175 |
$3.88 |
| 84703 |
|
13 |
12 |
$2.98 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
856 |
812 |
$1.82 |
| 36000 |
|
19 |
13 |
$0.45 |
| 99152 |
|
513 |
499 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
31 |
31 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18 |
18 |
$0.00 |
| 80299 |
|
14 |
13 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
1,088 |
1,031 |
$0.00 |
| C1769 |
Guide wire |
314 |
297 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
188 |
184 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
14 |
14 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
85 |
81 |
$0.00 |
| 84132 |
|
34 |
31 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
35 |
35 |
$0.00 |